FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.
If you need to generate income from your investments, selecting securities or funds based on their current interest or ...
The stock looks like a decent value, but it could be a bargain if management can execute. Its dividend checks all the boxes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results